All Stories

  1. Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis

    Article • PLOS One, August 2020, PLOS

    MD, PhD NOBUAKI MIYAHARA

  2. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2017, Dove Medical Press

    MD, PhD NOBUAKI MIYAHARA

  3. IL-23 Is Essential for the Development of Elastase-Induced Pulmonary Inflammation and Emphysema

    Article • American Journal of Respiratory Cell and Molecular Biology, November 2016, American Thoracic Society

    MD, PhD NOBUAKI MIYAHARA